Landscapes / Cell therapy

In vivo CAR-T landscape

16 drugs in 19 active trials · Every stage · updated 16 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs16

DrugHow it worksCompanyStageNext dateDetails
In vivo CD19 CAR-T, mRNA in lipid nanoparticles
CREATE Medicines · Private
Phase 1/2 1 Dec 2028Phase 1/2 trial completes
In vivo CD19 CAR-T
Phase 1 Dec 2026Phase 1 trial completes
In vivo BCMA CAR-T
Phase 1 Mar 2027Phase 1 trial completes
In vivo CAR-T, mRNA in lipid nanoparticles, target not disclosed
Early Phase 1 30 May 2027Early Phase 1 trial completes
In vivo CD19 CAR-T, mRNA in CD8-targeted lipid nanoparticles
Phase 1 31 May 2027Phase 1 trial completes
In vivo BCMA CAR-T
Vyriad · Private
Phase 1 31 Aug 2027Phase 1 trial completes
In vivo BCMA CAR-T, lentiviral
AstraZeneca +1 · Public AZN
Early Phase 1 30 Nov 2027Early Phase 1 trial completes
In vivo CD19 CAR-T, mRNA in T-cell-targeted lipid nanoparticles
AbbVie · Public ABBV
Phase 1 Nov 2027Phase 1 trial completes
In vivo CD19 CAR, circular RNA in targeted lipid nanoparticles
Phase 1 19 Dec 2027Early Phase 1 trial completes
In vivo CAR-T, target not disclosed
Phase 1 31 Dec 2027Phase 1 trial completes
In vivo CAR-T for blood cancers, target not disclosed
Tcelltech · Private
Phase 1 15 Oct 2028Phase 1 trial completes
In vivo CLL-1 CAR-T, lentiviral
Phase 1 31 Oct 2028Phase 1 trial completes
In vivo CD19 CAR-T, lentiviral
Umoja Biopharma · Private
Phase 1 Mar 2029Phase 1 trial completes
In vivo CAR-T (CD19, BCMA and CD70 CARs), lentiviral
Early Phase 1 30 May 2029Early Phase 1 trial completes
In vivo CD19 CAR-T
Bristol Myers Squibb · Public BMY
Phase 1 20 Oct 2032Phase 1 trial completes
In vivo CD20 CAR (T and NK cells), lentiviral
Gilead (Kite) · Public GILD
Phase 1 —

About this list

Matches
Conditions, trial titles, drug names and codes, other names, how it works and company.
Checked
16 of 16 drugs. How we check
Sources
ClinicalTrials.gov updated 16 Nov 2026 · openFDA updated 13 Nov 2026 · Company press releases
Ask your AI about this landscape. Connect it once, then ask in plain English.
Which companies run in vivo CAR-T trials, and in which countries?
Connect your AI

Which should we check next?

Need a landscape built for you? Talk to us.

Follow In vivo CAR-T

Following is part of Solo: you see every change to In vivo CAR-T the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in